“To give cancer patients swifter access to specifically targeted treatments with few side-effects” – that is the mission of our company

PD Dr. Barbara Mayer and PD Ilona Funke, the founders of Spherotec GmbH

• Early identification of promising drug candidates
• Early recognition of undesirable side effects
• Optimization of life-cycle management of drugs
• Sparing and targeted use of animal experiments